WASHINGTON, June 17 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to InvaDerm Inc. from its Center for Drug Evaluation and Research:

* * *

Recipient: Dilip Solanki, CEO, InvaDerm, Inc., 25 Worlds Fair Drive, Somerset, NJ 08873-1344, United States, dilip.solanki@inva-derm.com

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

WARNING LETTER

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products